Here’s what’s happening today in the world of CBD research, products and announcements: It’s Time To Remove Cannabis From The Federal Drug Schedules “One reason there has been so little in the United States is precisely because cannabis is listed on Schedule I, a designation that creates significant barriers toRead More →
Dr. M-J Milloy holds the inaugural post of Canopy Growth Professor of Cannabis Science at the University of British Columbia. He says there’s still so much research needed to confirm our beliefs about the effects of cannabis on human subjects. Dr. Milloy is interested to see if cannabis offers treatmentRead More →
![Evaluating the Therapeutic Potential of Cannabinoids: How to conduct research within the current regulatory framework [VIDEO]](https://www.crforum.io/wp-content/uploads/2018/12/fda-690x500.jpg)
On December 8, 2018, the following NIH-sponsored proceeding took place: “Evaluating the Therapeutic Potential of Cannabinoids: How to conduct research within the current regulatory framework“ From the website: The National Center for Complementary and Integrative Health (NCCIH), at the National Institutes of Health (NIH), sponsored a workshop on December 8,Read More →
Canada continues to lead the way in terms of applied cannabis research. The Ontario Long Term Care Association is embarking on a study of 500 seniors in the Ontario region to study the effects of cannabis use among seniors in long-term care. The outcomes of the study will inform policyRead More →
JAMA Network Open recently published a report entitled “Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis.” The piece presented the main questions examined in the study: How does smoked and vaporized cannabis acutely influence subjective drug effects, cognitive and psychomotor performance, and cardiovascular measures inRead More →
According to a recent article in The Stranger, Seattle-based Verda Bio is the first company in the state of Washington to be issued an official license to conduct cannabis research. The company is going to focus initially on plants that produce so-called “minor cannabinoids” — lesser known compounds that occurRead More →
In spite of legalization of cannabis happening throughout much of the U.S. and full legalization in Canada, the state of medical research of cannabis is lagging behind in the United States. Legalization in other countries has paved the way for much easier access to research and standardization in the industry.Read More →
A recent study from the University of Göttingen shows promise and the need for further study regarding the use of a synthetic form of tetrahydrocannabinol in the treatment of Alzheimer’s in mice. Treated mice lost less brain matter compared to the placebo group and also did not accumulate sticky plaque associatedRead More →
According to a recent article posted in the Pain News Network, clinical trials involving the study of cannabis and CBD in a variety of interventional settings are expected to take off now that regulations around such investigations seem to be loosening up for the Canadian and U.S.-based research communities thanksRead More →
According to a recent report, clinical trials have begin at the University of Mississippi Medical Center to study the use of cannabidiol (also known as CBD) for the treatment of children with severe epilepsy. The initial trial will involve ten children from Mississippi with severe cases of epilepsy. Harper Grace’s Law,Read More →